CLINICAL_TRIALS
trial_result
· 2021-06-10
Clinical Trial Update: Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men [Phase 3]
Summary
Phase 3 trial update on ambulatory blood pressure monitoring in men with hypogonadism treated with oral testosterone undecanoate (LPCN 1021).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lipocine Inc. | Conditions: Hypogonadism, Male | Phase 3 | Status: COMPLETED | Results posted: 2021-06-10